CD8A and cancer: In this study, FGL2 was found to be positively correlated with the critical steps of the cancer-immunity cycle, including the release of cancer cell antigens (Step 1) and trafficking of immune cells to tumors (Step 4) (CD8 T cell recruiting, Th1 cell recruiting, DC recruiting, NK cell recruiting, and TH17 recruiting) (Figure 7E).